NTX-001 to Repair Peripheral Nerve Transection(s)
Trial statusAvailable
Trial phaseNot listed
Trial typeExpanded Access
Biological sexAll
Age12-80
SponsorNeuraptive Therapeutics Inc.
About this trial
The proposed use of NTX-001 for transections of upper extremity and facial peripheral nerves, acutely or planned.
Eligibility criteria
Qualifiers
Patients whose nerve repair will occur greater than 48 hours after nerve transection.
Patients requiring repair of the intracranial portion of any nerve.
Patients requiring a nerve repair involving an allograft or conduit.
Patients expected to show signs of spontaneous recovery by 12 months (e.g., Bell's palsy).
Disqualifiers
None
Trial design
Treatments tested in this trial
- NTX-001
Treatment groups
No treatment groups listed
Sponsors and collaborators
Source ClinicalTrials.gov